Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion

Exelon Corporation $EXC Stake Trimmed by Miller Howard Investments Inc. NY

Exelon logo with Utilities background
Image from MarketBeat Media, LLC.

Key Points

  • Miller Howard Investments reduced its Exelon stake by 2.9% in the third quarter, selling 46,266 shares and retaining 1.57 million shares valued at approximately $63.6 million. Institutional investors collectively own 80.92% of Exelon.
  • Analysts have mostly maintained a cautious outlook, with six Buy, thirteen Hold, and one Sell rating. Exelon’s consensus rating is Hold, with an average price target of $48.58.
  • Exelon reported quarterly revenue of $5.97 billion, up 10% year over year, but earnings per share of $0.43 narrowly missed estimates. The company reaffirmed fiscal 2026 EPS guidance of $2.81–$2.91.
  • Want to know the moment analysts change their view on Exelon? Get MarketBeat All Access for $149 a year and keep that rate for life.

Miller Howard Investments Inc. NY trimmed its holdings in shares of Exelon Corporation (NASDAQ:EXC - Free Report) by 2.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,574,164 shares of the company's stock after selling 46,266 shares during the quarter. Exelon accounts for approximately 1.7% of Miller Howard Investments Inc. NY's holdings, making the stock its 17th biggest holding. Miller Howard Investments Inc. NY owned approximately 0.15% of Exelon worth $63,596,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in EXC. Eastern Bank bought a new position in shares of Exelon during the 2nd quarter valued at approximately $26,000. Axiom Investment Management LLC purchased a new stake in Exelon during the 1st quarter valued at $27,000. Elevation Wealth Partners LLC lifted its position in Exelon by 440.0% in the second quarter. Elevation Wealth Partners LLC now owns 594 shares of the company's stock worth $28,000 after buying an additional 484 shares during the last quarter. Silvant Capital Management LLC bought a new stake in Exelon in the second quarter worth $29,000. Finally, North Point Portfolio Managers Corp OH bought a new stake in Exelon in the third quarter worth $29,000. Institutional investors own 80.92% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on EXC shares. Argus dropped their price objective on shares of Exelon from $52.00 to $49.00 and set a "buy" rating for the company in a research note on Tuesday, September 22nd. The Goldman Sachs Group reduced their target price on shares of Exelon from $45.00 to $44.00 in a research note on Thursday, October 15th. Truist Financial lowered their target price on shares of Exelon from $48.00 to $46.00 and set a "hold" rating for the company in a report on Friday, October 16th. Barclays dropped their price target on shares of Exelon from $49.00 to $44.00 and set an "equal weight" rating for the company in a research note on Monday, October 19th. Finally, Morgan Stanley cut their price target on shares of Exelon from $50.00 to $49.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 21st. Six equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Exelon has a consensus rating of "Hold" and a consensus target price of $48.58.

View Our Latest Research Report on EXC

Exelon Trading Up 0.2%

Shares of NASDAQ EXC opened at $44.54 on Tuesday. Exelon Corporation has a fifty-two week low of $39.73 and a fifty-two week high of $50.65. The company has a debt-to-equity ratio of 1.71, a quick ratio of 0.99 and a current ratio of 1.09. The company has a market cap of $45.98 billion, a price-to-earnings ratio of 16.32, a PEG ratio of 2.43 and a beta of 0.30. The business's 50 day moving average price is $42.85 and its 200-day moving average price is $45.53.

Exelon (NASDAQ:EXC - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported $0.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.44 by ($0.01). The business had revenue of $5.97 billion for the quarter, compared to analysts' expectations of $5.44 billion. Exelon had a net margin of 10.99% and a return on equity of 9.81%. Exelon's revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.39 EPS. Exelon has set its FY 2026 guidance at 2.810-2.910 EPS. On average, sell-side analysts expect that Exelon Corporation will post 2.86 earnings per share for the current year.

Exelon Profile

(Free Report)

Exelon Corporation NASDAQ: EXC is a regulated utility holding company that delivers electricity and natural gas to residential, commercial and industrial customers. The company operates through six utility subsidiaries: Atlantic City Electric, Baltimore Gas and Electric, Commonwealth Edison, Delmarva Power, PECO and Pepco. Its businesses focus primarily on the transmission, distribution and delivery of energy rather than owning competitive power-generation operations.

Exelon's utilities serve customers across Illinois, Pennsylvania, Maryland, Delaware, New Jersey and the District of Columbia.

Further Reading

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Corporation (NASDAQ:EXC - Free Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines